Given the heterogeneity in study design, populations, intervention duration, and clinical endpoints, findings were interpreted with careful consideration of variability across the evidence base
The brand qualifies this with the following: results vary based on starting weight and program adherence, individual results are not typical and may vary, claims are based on self-reported customer data rather than clinical trials, and medication prescriptions are at the discretion of medical providers
To further describe this bioinformatic output, KEGG-based pathway analysis was performed, in which upregulated proteins were positioned within the functional processes of porcine metabolism
Supplementary information Supplementary Figures and Tables (PDF 594 kb) PowerPoint slides Rights and permissions About this article Cite this article Muskiet, M., Tonneijck, L., Smits, M
Exenatide, when combined with metformin, has been shown to significantly suppress the proliferation of breast cancer cells [104]
Among the top 12, the biggest climbers were AstraZeneca, Eli Lilly, and Novo Nordisk, with Roche also experiencing double-digit growth
